APOE and Alzheimer disease: Genome-wide association studies (GWAS) have identified close to 80 loci associated with AD risk, with the APOE ε4 allele representing the most significant contributor (Marioni et al., 2017; Jansen et al., 2019; Kunkle et al., 2019; Bellenguez et al., 2022).